Skip to main content

Table 1 Relationships of the clinicopathologic characteristics and single chromosomal loss

From: The gene-reduction effect of chromosomal losses detected in gastric cancers

Characteristics   3p loss 4p loss 5q loss 8p loss 9p loss 13q loss 17p loss 18q loss
No. of patients 130 47 47 51 30 50 57 77 55
Age          
   Mean 60 61 63 63 63 64 63 63 63
   ± SD ± 12.60 ± 10.18 ± 10.49 ± 9.28 ± 10.24 ± 10.28 ± 10.43 ± 10.94 ± 11.20
   P   0.290 0.029 0.014 0.102 0.003 0.030 < 0.0001 0.030
Sex          
   Male 86 37 34 36 18 37 42 52 36
   Female 44 10 13 15 12 13 15 25 19
   P   0.033 0.335 0.450 0.510 0.182 0.136 0.710 1.000
Tumor location          
   Cardia 13 4 3 5 1 2 5 8 3
   Body 48 16 16 13 10 14 16 24 16
   Antrum 69 27 28 33 19 34 36 45 36
   P   0.743 0.424 0.078 0.267 0.018 0.119 0.253 0.043
Histologic type          
   Intestinal 54 19 19 23 13 22 20 36 27
   Diffuse 32 9 9 6 5 8 15 11 7
   Mixed 44 19 19 22 12 20 22 30 21
   P   0.395 0.395 0.018 0.480 0.176 0.404 0.004 0.026
Tumor size          
   Mean 5.3 5.8 5.1 4.9 5.1 4.9 5.7 5.2 5.5
   ± SD ± 3.01 ± 2.86 ± 2.64 ± 2.29 ± 2.42 ± 2.73 ± 3.02 ± 2.86 ± 3.13
   P   0.129 0.631 0.131 0.705 0.181 0.179 0.564 0.483
Stage          
   I & II 64 20 21 20 14 22 21 36 24
   III & IV 66 27 26 31 16 28 36 41 31
   P   0.277 0.469 0.075 0.836 0.372 0.014 0.593 0.292
Recurrence          
   Peritoneal 24 10 9 8 5 10 12 16 11
   Lymph node 10 4 3 3 2 5 4 6 3
   Hematogenous 22 13 11 14 8 11 14 15 10
   Total 56 27 23 25 15 26 30 37 24
   P   0.422 0.507 0.070 0.428 0.826 0.415 0.899 0.663
Vital status 119 42 41 47 29 44 51 68 48
   Alive 70 19 21 26 16 20 24 36 27
   Dead 49 23 20 21 13 24 27 32 21
   P   0.021 0.152 0.330 0.402 0.019 0.019 0.094 0.389
  1. P values less than 0.05 are indicated in boldface print.